Literature DB >> 15165294

Pneumonia due to Cryptococcus neoformans in a patient receiving infliximab: possible zoonotic transmission from a pet cockatiel.

Rabin K Shrestha1, James K Stoller, Golara Honari, Gary W Procop, Steven M Gordon.   

Abstract

The use of humanized antibody against tumor necrosis factor alpha (TNF-alpha) may increase the risk of various opportunistic infections, including tuberculosis and fungal infections. We report a case of cryptococcal pneumonia in a patient who was taking infliximab for rheumatoid arthritis. A temporally related exposure history raised the possibility that our patient acquired the infection from his pet cockatiel. It seems prudent to advise patients receiving infliximab to avoid exposure to pet avian excreta.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15165294

Source DB:  PubMed          Journal:  Respir Care        ISSN： 0020-1324            Impact factor:   2.258


  11 in total

1.  Case Series: Report of the First Two Human Indigenous Cases of Cryptococcus gattii Infection in Eastern Canada.

Authors:  Jessica St-Pierre; Philippe J Dufresne; Alex Carignan; Émilie Lévesque; Francis Bernard; Jean Longtin; Louiselle LeBlanc
Journal:  Mycopathologia       Date:  2017-10-30       Impact factor: 2.574

Review 2.  Disseminated aspergillosis following infliximab therapy in an immunosuppressed patient with Crohn's disease and chronic hepatitis C: a case study and review of the literature.

Authors:  Joel W Alderson; Thomas G Van Dinter; Michael J Opatowsky; Elizabeth C Burton
Journal:  MedGenMed       Date:  2005-09-21

3.  First case of human cryptococcosis due to Cryptococcus neoformans var. gattii in Spain.

Authors:  M Francisca Colom; Susana Frasés; Consuelo Ferrer; Alejandro Jover; Mariano Andreu; Sergio Reus; Manuel Sánchez; Josep M Torres-Rodríguez
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

Review 4.  COVID-19-associated opportunistic infections: a snapshot on the current reports.

Authors:  Amir Abdoli; Shahab Falahi; Azra Kenarkoohi
Journal:  Clin Exp Med       Date:  2021-08-23       Impact factor: 5.057

Review 5.  Dormancy in Cryptococcus neoformans: 60 years of accumulating evidence.

Authors:  Alexandre Alanio
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

6.  Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases.

Authors:  Nirmal Kaur; Thomas C Mahl
Journal:  Dig Dis Sci       Date:  2007-04-11       Impact factor: 3.487

7.  Confronting zoonoses, linking human and veterinary medicine.

Authors:  Laura H Kahn
Journal:  Emerg Infect Dis       Date:  2006-04       Impact factor: 6.883

8.  [Requirements for hygiene in the medical care of immunocompromised patients. Recommendations from the Committee for Hospital Hygiene and Infection Prevention at the Robert Koch Institute (RKI)].

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2010-04       Impact factor: 1.513

9.  Invasive Cryptococcosis and adalimumab treatment.

Authors:  Juan P Horcajada; Jose L Peña; Víctor M Martínez-Taboada; Trinitario Pina; Isabel Belaustegui; María Eliecer Cano; Daniel García-Palomo; M Carmen Fariñas
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

Review 10.  Possible environmental exposure-associated pulmonary cryptococcosis in a patient with rheumatoid arthritis: a case report and literature review.

Authors:  Guangdie Yang; Junjun Chen; Jiani Ye; Yinan Yao; Zhijie Pan
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.